Cargando…
(77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions
Detailed investigation of ligand–protein interactions is essential for better understanding of biological processes at the molecular level. Among these binding interactions, the recognition of glycans by lectins is of particular importance in several diseases, such as cancer; therefore, inhibition o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779653/ https://www.ncbi.nlm.nih.gov/pubmed/35057096 http://dx.doi.org/10.3390/pharmaceutics14010201 |
_version_ | 1784637629571006464 |
---|---|
author | Timári, István Balla, Sára Fehér, Krisztina Kövér, Katalin E. Szilágyi, László |
author_facet | Timári, István Balla, Sára Fehér, Krisztina Kövér, Katalin E. Szilágyi, László |
author_sort | Timári, István |
collection | PubMed |
description | Detailed investigation of ligand–protein interactions is essential for better understanding of biological processes at the molecular level. Among these binding interactions, the recognition of glycans by lectins is of particular importance in several diseases, such as cancer; therefore, inhibition of glycan-lectin/galectin interactions represents a promising perspective towards developing therapeutics controlling cancer development. The recent introduction of (77)Se NMR spectroscopy for monitoring the binding of a selenoglycoside to galectins prompted interest to optimize the sensitivity by increasing the (77)Se content from the natural 7.63% abundance to 99%. Here, we report a convenient synthesis of (77)Se-enriched selenodigalactoside (SeDG), which is a potent ligand of the medically relevant human galectin-3 protein, and proof of the expected sensitivity gain in 2D (1)H, (77)Se correlation NMR experiments. Our work opens perspectives for adding isotopically enriched selenoglycans for rapid monitoring of lectin-binding of selenated as well as non-selenated ligands and for ligand screening in competition experiments. |
format | Online Article Text |
id | pubmed-8779653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87796532022-01-22 (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions Timári, István Balla, Sára Fehér, Krisztina Kövér, Katalin E. Szilágyi, László Pharmaceutics Article Detailed investigation of ligand–protein interactions is essential for better understanding of biological processes at the molecular level. Among these binding interactions, the recognition of glycans by lectins is of particular importance in several diseases, such as cancer; therefore, inhibition of glycan-lectin/galectin interactions represents a promising perspective towards developing therapeutics controlling cancer development. The recent introduction of (77)Se NMR spectroscopy for monitoring the binding of a selenoglycoside to galectins prompted interest to optimize the sensitivity by increasing the (77)Se content from the natural 7.63% abundance to 99%. Here, we report a convenient synthesis of (77)Se-enriched selenodigalactoside (SeDG), which is a potent ligand of the medically relevant human galectin-3 protein, and proof of the expected sensitivity gain in 2D (1)H, (77)Se correlation NMR experiments. Our work opens perspectives for adding isotopically enriched selenoglycans for rapid monitoring of lectin-binding of selenated as well as non-selenated ligands and for ligand screening in competition experiments. MDPI 2022-01-15 /pmc/articles/PMC8779653/ /pubmed/35057096 http://dx.doi.org/10.3390/pharmaceutics14010201 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Timári, István Balla, Sára Fehér, Krisztina Kövér, Katalin E. Szilágyi, László (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions |
title | (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions |
title_full | (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions |
title_fullStr | (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions |
title_full_unstemmed | (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions |
title_short | (77)Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions |
title_sort | (77)se-enriched selenoglycoside enables significant enhancement in nmr spectroscopic monitoring of glycan–protein interactions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779653/ https://www.ncbi.nlm.nih.gov/pubmed/35057096 http://dx.doi.org/10.3390/pharmaceutics14010201 |
work_keys_str_mv | AT timariistvan 77seenrichedselenoglycosideenablessignificantenhancementinnmrspectroscopicmonitoringofglycanproteininteractions AT ballasara 77seenrichedselenoglycosideenablessignificantenhancementinnmrspectroscopicmonitoringofglycanproteininteractions AT feherkrisztina 77seenrichedselenoglycosideenablessignificantenhancementinnmrspectroscopicmonitoringofglycanproteininteractions AT koverkataline 77seenrichedselenoglycosideenablessignificantenhancementinnmrspectroscopicmonitoringofglycanproteininteractions AT szilagyilaszlo 77seenrichedselenoglycosideenablessignificantenhancementinnmrspectroscopicmonitoringofglycanproteininteractions |